- ISIN
- US81684M1045
- CUSIP
- 81684M104
- Delisting Date
- Jan 20, 2026
- Sector
- Healthcare
- Industry
- Medical Devices
- IPO Date
- Feb 21, 2014
Highlights
- Market Cap
- $336.36M
- Enterprise Value
- $462.61M
- EPS (TTM)
- $3.22
- PE Ratio
- 6.31
- PEG Ratio
- 0.19
- Total Revenue (TTM)
- $36.96M
- Gross Profit (TTM)
- $33.54M
- EBITDA (TTM)
- -$46.64M
- Year Range
- $14.89 - $48.77
- Target Price
- $61.00
- ROA (TTM)
- 8.10%
- ROE (TTM)
- 10.51%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
SMLR Performance Chart
Loading charts...
Returns By Period
Semler Scientific, Inc.
- 1D
- —
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
SMLR Monthly Returns History
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 32.96% | 32.96% | |||||||||||
| 2025 | -3.78% | -17.40% | -15.66% | -10.69% | 23.72% | -3.15% | -7.46% | -17.32% | 1.21% | -11.80% | -17.91% | -29.60% | -71.69% |
| 2024 | 0.00% | 6.50% | -38.08% | -12.60% | 14.88% | 17.29% | -3.63% | -19.46% | -11.80% | 24.76% | 94.08% | -5.30% | 21.92% |
| 2023 | 18.82% | -43.89% | 21.82% | 4.78% | -2.10% | -4.55% | -6.44% | 7.37% | -3.76% | 14.98% | 32.12% | 14.92% | 34.21% |
| 2022 | -17.44% | -3.53% | -32.11% | -7.20% | -39.42% | 1.15% | 10.11% | 47.31% | -17.85% | 11.88% | -29.45% | 11.34% | -63.99% |
| 2021 | -5.45% | 15.89% | 4.37% | 5.35% | -2.87% | 1.63% | 5.56% | -10.17% | 17.95% | 19.96% | -35.74% | -4.91% | -2.50% |
Benchmark Metrics
Semler Scientific, Inc. has an annualized alpha of 35.00%, beta of 0.99, and R2 of 0.04 versus S&P 500 Index. Calculated based on daily prices since February 21, 2014.
- This stock participated in 111.39% of S&P 500 Index downside but only 105.13% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.04 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 35.00%
- Beta
- 0.99
- R²
- 0.04
- Upside Capture
- 105.13%
- Downside Capture
- 111.39%
Return for Risk
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Semler Scientific, Inc. (SMLR) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SMLR | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.37 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 2.78 | — |
| Martin ratioReturn relative to average drawdown | — | 12.44 | — |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Semler Scientific, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Semler Scientific, Inc. was 89.86%, occurring on Dec 30, 2025. The portfolio has not yet recovered.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2025 bear market2025 | -89.86%Dec 2025 | 4y 2mo | — | 4y 7moNov 2021 - now |
2016 bear market2016 | -80.57%Jun 2016 | 2y 4mo | 1y 4mo | 3y 8moFeb 2014 - Nov 2017 |
COVID crash2020 | -44.50%Mar 2020 | 27d | 4mo 10d | 5mo 7dFeb 2020 - Jul 2020 |
Rate-hike selloffLate 2018 | -28.84%Nov 2018 | 1mo 23d | 1mo 27d | 3mo 20dOct 2018 - Jan 2019 |
2019 bear market2019 | -27.60%Oct 2019 | 2mo 9d | 4mo 13d | 6mo 22dAug 2019 - Feb 2020 |
Drawdown Indicators
| SMLR | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | — | -56.78% | — |
Max Drawdown (1Y)Largest decline over 1 year | — | -9.10% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | — | -1.80% | — |
Average DrawdownAverage peak-to-trough decline | — | -10.71% | — |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 2.03% | — |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Semler Scientific, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Semler Scientific, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for SMLR, comparing it with other companies in the Medical Devices industry. Currently, SMLR has a P/E ratio of 6.3. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for SMLR compared to other companies in the Medical Devices industry. SMLR currently has a PEG ratio of 0.2. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for SMLR relative to other companies in the Medical Devices industry. Currently, SMLR has a P/S ratio of 8.3. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for SMLR in comparison with other companies in the Medical Devices industry. Currently, SMLR has a P/B value of 0.7. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with SMLR
Add Semler Scientific, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with SMLR